P,53 INHIBITOR ENHANCES TEMOZOLOMIDE CYTOTOXIC ACTIVITY AGAINST GBM

被引：0
|
作者：
James, C. David [1 ]
Dinca, Eduard
Lu, Kan [1 ]
Prados, Michael [1 ]
Vandenberg, Scott [1 ]
Sarkaria, Jann
Haas-Kogan, Daphne [1 ]
Berger, Mitchel [1 ]
Pieper, Russell [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
NEURO-ONCOLOGY | 2008年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：796 / 797
页数：2
相关论文
共 50 条
  • [41] The p53-inhibitor pifithrin enhances NF-kB activity and protects brain tissue in models of acute brain injury
    Culmsee, C
    Baumgarten, LV
    Junker, V
    Krieglstein, J
    Plesnila, N
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2004, 369 : R83 - R83
  • [42] MDM2-p53 Inhibitor Alrizomadlin (APG-115) Enhances Antitumor Activity of Pomalidomide in Multiple Myeloma (MM)
    Wang, Guangfeng
    Liang, Eric
    Min, Ping
    Ge, Yangfeng
    Wu, Bingxing
    Yu, Huidan
    Yang, Dajun
    Zhai, Yifan
    BLOOD, 2022, 140 : 9953 - 9954
  • [43] Pretreatment with the mTOR Inhibitor Everolimus Enhances Glioblastoma Sensitivity to Temozolomide in Vitro
    McLean, Aaron Lawson
    Freitag, Diana
    Kalif, Rolf
    Walter, Jan
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 37 - 37
  • [44] INHIBITION OF CBP/P300 HISTONE ACETYLATION ACTIVITY ENHANCES TEMOZOLOMIDE ACTIVITY IN GLIOBLASTOMA PATIENT DERIVED XENOGRAFTS
    Kitange, Gaspar J.
    Burgenske, Danielle M.
    Bakken, Katrina K.
    Hu, Zeng
    He, Lihong
    Carlson, Brett L.
    Wilson, Jonathan
    Bommi-Reddy, Archana
    Conery, Andy
    Sarkaria, Jann
    NEURO-ONCOLOGY, 2020, 22 : 89 - 89
  • [45] p53 status modifies cytotoxic activity of lactoferrin under hypoxic conditions
    Kosim, Maryami Yuliana
    Fukazawa, Takahiro
    Miyauchi, Mutsumi
    Hirohashi, Nobuyuki
    Tanimoto, Keiji
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [46] Neuropilin-1 enhances temozolomide resistance in glioblastoma via the STAT1/p53/p21 axis
    Huang, Ping
    Zhang, Lixia
    Wang, Hongwei
    Dou, Changwu
    Ju, Haitao
    Yue, Peng
    Ren, Jiaxing
    NEUROPATHOLOGY, 2024, 44 (04) : 319 - 330
  • [47] The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents
    Canon, Jude
    Osgood, Tao
    Olson, Steven H.
    Saiki, Anne Y.
    Robertson, Rebecca
    Yu, Dongyin
    Eksterowicz, John
    Ye, Qiuping
    Jin, Lixia
    Chen, Ada
    Zhou, Jing
    Cordover, David
    kaufman, Stephen
    Kendall, Richard
    Oliner, Jonathan D.
    Coxon, Angela
    Radinsky, Robert
    MOLECULAR CANCER THERAPEUTICS, 2015, 14 (03) : 649 - 658
  • [48] Pyridoxatin, an inhibitor of gelatinase A with cytotoxic activity
    Lee, HJ
    Chung, MC
    Lee, CH
    Chun, HK
    Kim, HM
    Kho, YH
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 1996, 6 (06) : 445 - 450
  • [49] The histone deacetylase inhibitor depsipeptide (FR901228) enhances the cytotoxic activity of Ad5-TRAIL against prostate and renal tumor cells
    VanOosten, RL
    Moore, JM
    Griffith, TS
    FASEB JOURNAL, 2004, 18 (04): : A62 - A62
  • [50] The histone deacetylase inhibitor depsipeptide (FR901228) enhances the cytotoxic activity of Ad5-TRAIL against human prostate tumor cells
    Griffith, TS
    Moore, J
    Van Oosten, R
    MOLECULAR THERAPY, 2004, 9 : S361 - S362
12345